Predictors of Treatment Outcomes in ANCA-Associated Vasculitis with Severe Kidney Failure

Abstract

Although low baseline renal function and severe renal scarring are associated with lower treatment response rate, no "futility" threshold could be identified. Conversely, continued immunosuppressive therapy beyond 4 months is unlikely to benefit patients who remain dialysis dependent.